Hims & Hers Health shares are under pressure after JPMorgan trimmed its price target following a messy first quarter. The note signals growing caution around the company's near-term fundamentals and earnings trajectory. The impact is likely stock-specific rather than sector-wide.
Hims & Hers Health shares are under pressure after JPMorgan trimmed its price target following a messy first quarter. The note signals growing caution around the company's near-term fundamentals and earnings trajectory. The impact is likely stock-specific rather than sector-wide.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment
